Introduction
Semiconductor nanocrystals, which are referred to as quantum dots (QDs), have gain much attention since it was first introduced by Louis Brus and Alexi Ekimov in 1980s (Ekimov et al. 1985; Rossetti et al. 1983) . These "artificial atoms" exhibit unique electronic and optical properties such as tunable band gaps, high quantum yields, broad absorption spectra, narrow emission spectra and high resistance to photobleaching. During the past decade, QDs have been developed for a broad range of applications. In the optoelectronic fields, great success has been achieved of using QDs in solar energy conversion, light emitting diodes (LEDs), lasers, and display devices (Coe et al. 2002; Huffaker et al. 1998; Huynh et al. 2002; Likharev 1999) . 3 Meanwhile, in the biomedicine fields, QDs are also successfully utilized as biomedical imaging or traceable drug delivery agents to label biological molecules, cells and even tissues (Resch-Genger et al. 2008 ), or to follow drug molecules in live organisms (Bagalkot et al. 2007; Manabe et al. 2006) . With the spring up of the nascent QD industry, human being is inevitably exposed to these engineered nanomaterials and the studies on the potential toxicity of manufactured QDs become urgent and crucial. Recently, a number of in vitro studies have evaluated the toxicity of QDs in different types of cells. For example, Tang et al. tested the neurotoxicity of CdSe QDs in a hippocampal neuronal culture model and a dose-dependent cell death was observed with 24 h continuously exposure to QDs (Tang et al. 2008) . Core QDs and QDs with different coatings were also reported to be toxic to primary rat hepatocytes (Shiohara et al. 2004 ). In addition, the cadmium based QDs were demonstrated to induce dramatic cell loss in pancreatic carcinoma cells (PANC-1), rat pheochromocytoma cells (PC12) and murine microglial cells (N9) (Chang et al. 2009; Lovric et al. 2005) . Although these toxicological studies have shown the toxicity results of cell death for some primary or immortalized cell lines (Derfus et al. 2004; Su et al. 2009; Tang et al. 2008) , the understanding of QDs cytotoxicity remains limited.
Lately, QDs were reported to label dermal, adipose, tumor and retinal vasculature (Cai et al. 2006; Jayagopal et al. 2007; Larson et al. 2003) . These angiographic techniques provide noninvasive optical access to the vasculature and continuous monitoring of vascular functions. Moreover, Manabe et al. injected QD-conjugated captopril (anti-hypertensive drug) into stroke-prone spontaneously hypertensive rats 4 (SHRSP) and analyzed their kinetics and dynamics (Manabe et al. 2006) . QDs therefore appear to be a powerful tool for elucidating the pharmacokinetics and pharmacodynamics of drug candidates. However, these novel techniques raised concerns about QDs toxicity on the toxin-susceptible vascular system, especially on the endothelium. Because QDs are need to be directly injected into vascular for these applications, and thus may interact with and impair vascular endothelial cells (ECs), which line the luminal surface of all blood vessels.
The vascular ECs represent a dynamic interface between the circulatory system and the nonvascular tissues, and therefore protect nonvascular tissues such as brain from harmful substances (Lum and Malik 1994) . Besides their barrier function, they also play an important role in maintaining vascular homeostasis by releasing various factors to influence vascular tone, thrombogenesis, inflammation, and vessel growth and remodeling (Cines et al. 1998) . Endothelial dysfunction and/or apoptosis, whether caused by physical injury or toxicants-induced cellular damage, are considered as early pathological features and independent predictors of poor prognosis in most forms of cardiovascular diseases (CVDs) (Choy et al. 2001; Halcox et al. 2002) .
Hence, the potential injuries of vascular ECs by QDs are expected to be cardiovascular risks for human. Furthermore, because mitochondrion is a key organelle in conversion of energy, regulation of cellular signaling as well as amplification of programmed cell death in eukaryotic cells including ECs, mitochondrial impairment is believed to induce endothelial dysfunction and promote a series of processes that initiate and exacerbate atherosclerosis (Davidson and Duchen 5 2007; Duchen 1999) . Previous studies have shown that mitochondria participate in the QDs-induced apoptotic insults to several cell types (Choi et al. 2007; Lovric et al. 2005b ). However, the questions of whether QDs can directly affect mitochondrial function, activate mitochondrial death pathways or even trigger apoptosis in ECs remain unanswered.
In this study, we synthesized mercaptosuccinic acid (MSA)-capped CdTe QDs directly via in aqueous condition, and investigated the direct effects of these CdTe QDs on endothelial injury, especially focusing on mitochondrial function and apoptosis. MSA-capped CdTe QDs were selected for this study because they have narrow band gaps and wide Bohr exciton radius, which equip them smaller sizes than most of CdSe QDs for red or near infrared (NIR) emission (Yu et al. 2003) ; and this enables CdTe QDs with different emission spectra tuned in a broader range can be effectively resolved over the same size range. Our QDs also have favorable pH-stability which supported resistance to the degradation under complicated biological environments. HUVECs were selected in our experiments as an in vitro model to assess the vascular toxicity of CdTe QDs. We found that CdTe QDs induced an increase in intracellular reactive oxygen species (ROS) generation, significant mitochondrial dysfunction, activated the mitochondrial death pathways and induced apoptotic cell death in human vascular ECs. Our results suggested that QDs in circulation could be a strong cardiovascular risk, and provide helpful guidance on the future safe use of QDs. Understanding the mechanisms underlying QD-toxicity will also help researchers improve the eventual design and manipulation of QDs to make 6 them more suitable tools in nanomedicine.
Materials and methods

Chemicals and aterials
Cadmium chloride (CdCl 2 , 99.0%), Tellurium powder (Te, 99.5%) were from Alfa Aesar (London, UK). Sodium borohydride (96%), hydrochloric acid (HCl) and sodium hydroxide (NaOH) were from Sinopharm Chemical Reagent Co., Ltd (Shanghai, China). All chemicals were used without further purification. Solutions were prepared using Milli-Q water (Millipore) as the solvent. Mercaptosuccinic acid 
Preparation and characterization of quantum dots
The CdTe QDs were synthesized based on the reaction of CdCl 2 and NaHTe solution with MSA as surfactant (Fu et al. 2010 The absorption spectra and emission spectra were recorded with a UV2550 scanning spectrophotometer (Shimadzu, Japan) and an F-2500 Spectrofluorometer (Hitachi, Japan), respectively. To measure their photostability in physiological environment and weak acidic environment, our as-prepared QDs and a similar commercial CdTe QDs 8 were dissolved in deionized ultra-pure water with a pH value adjusted to 7.4 or 5.0
with NaOH or HCl, respectively. Then the QD solutions were added into the microplate and their mean fluorescence intensities (MFI) at peak emission were measured at 405 nm excitation and 599 nm emission every 20 minutes for 15 h periods with a fluorescence microplate reader (Flexstation 3, Molecular Device). To determine the composition of CdTe QDs, the concentration of mercaptosuccinate capping ligands was determined by measuring the total organic carbon (TOC, TOC-VCPH, Shimadzu, Japan). The concentration of cadmium from QDs was measured by graphite furnace atomic absorption spectroscopy (GFAA, AA800
Spectrometer, Thermo scientific). To measure the free cadmium ions released from CdTe QDs, 2 mL CdTe QDs stock solution (1 mg/mL) was added into a dialysis tube (molecular-weight cutoff of 400 daltons, MWCO-400, 3M Co. Ltd.) and then placed in polypropylene beakers containing 500 mL ultra pure water. The dialysis experiment lasted for 24 h, and 2 mL was taken at the 6 th , 18 th and 30 th hour. Finally, the collected sample was analyzed using AAS. All the measurements were performed at room temperature and in triplicate.
Cell culture and treatments
Primary HUVECs were obtained from human umbilical cord veins according to Ling et a1. (Ling et al. 2003) . In brief, the vein was cannulated and filled with 0.1% type I collagenase. After incubation (37 °C, 15 min), the obtained pellets were centrifugated and resuspened in Medium200 with LSGS at a concentration of 10 5 cells/mL. The cells were used at passage 2 to 4 in our study. After reaching 90% 9 confluence, M200 with LSGS was removed and then HUVECs were cultured with M200 (containing 2% FBS) in the presence of CdTe QDs at different final concentrations (range from 0.1 to 100 μg/mL) for 12 or 24 h. Untreated control cells were incubated with medium (containing only 2% FBS) alone.
Cell viability assessment
The viability of HUVECs treated with CdTe QDs was estimated with both 
Detection of cellular apoptosis
Exposed membrane phosphatidylserine (PS) in apoptotic cells induced by QDs was identified by flow cytometry (FCM) using a commercial apoptosis detection kit The involvement of ROS in CdTe QDs-induced apoptosis was also examined by this FCM assay. In brief, HUVECs were pre-incubated with an antioxidant and ROS scavenger N-acetylcysteine (NAC, 1 mM) for 2 h and then with a QDs suspension (10 μg/mL) for an additional 24 h. To study whether CdTe QDs-induced apoptosis in
HUVECs was caspase-dependent, caspase inhibitors Z-VAD-FMK (50 μM) or Ac-DEVD-CHO (20 mΜ) were incubated with HUVECs for 1 h prior to the addition of QDs (10 μg/mL). Then, after treatment, the apoptotic HUVECs were also detected on the FL-1 detector (530 ± 15 nm, band pass) of the FACScalibur flow cytometer. 
Evaluation of intercellular ROS
Visualization of mitochondria structure
To examine mitochondrial structure in HUVECs treated with QDs for 24 h, MitoTracker Red FM (1 μM) was added after twice PBS washing. After a short incubation period of 15 minutes, the fluorescence images of mitochondria were obtained using a LSM510 laser scanning confocal microscope (Carl Zeiss, Germany).
Cytochrome c immunostaining in QDs treated HUVECs
The release of cytochrome c from mitochondria was detected using 12 immunostaining analysis. Briefly, HUVECs were washed twice with PBS and loaded with 100 μM MitoTracker Red FM for 20 minutes after 24 h QDs treatment. Then, cells were fixed with 3.7% paraformaldehyde and permeabilized for immunostaining.
Mouse polyclonal anti-cytochrome c (1:200) and FITC-conjugated mouse IgG (1:500)
were used. The translocation of cytochrome c from mitochondria to cytoplasm was observed by a Carl-Zeiss LSM 510 confocal laser microscope.
Immunoblot analysis of cellular expression of apoptotic proteins
HUVECs exposed to CdTe QDs for 24 h were rinsed with cold PBS and lysed for 30 min in cold radioimmune precioitation assay (RIPA) buffer (1% Triton X-100, 50
mM Tris/HCl, pH 7.4, 300 mM NaCl, 10 µg/mL aprotinin, 10 µg/mL leupeptin, 1 mM sodium orthovanadate, and 2 mg/mL iodoacetamide). After removing cellular debris by centrifugation (13,000 rpm, 10 min, 4 °C), the cell lysates were subjected to 12% sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and subsequently transferred onto polyvinylidene difluoride (PVDF) membranes (Millipore). Blocking of unspecific binding sites with nonfat dry milk (5% in Tris-buffered saline containing 0.1% Tween-20) was followed by incubation with primary antibodies (Bcl-2 1:500; Bax 1:1000; caspase-9 1:500; caspase-3 1:1000), which were detected with horseradish peroxidase (HRP)-conjugated secondary antibodies, using a TMB Liquid Substrate kit.
Statistical analysis
Experiments were performed at least three times. Data were presented as mean ± SD and evaluated for statistical significance by one-or two-way analysis of variance, 13 followed by a post hoc test.
Results
Characterizations of CdTe QDs
HRTEM images (Fig.1A) showed that the CdTe QDs as-prepared have a highly crystalline nature and a very uniform size (~ 4 nm). The typical visible absorption and photoluminescence (PL) spectra of CdTe QDs in Fig.1B showed that the QDs has a narrow, symmetric emission spectra (about 60 nm full width at half maximum, FWHM) and the emission peak at 599 nm. According to Peng et al. (Yu et al. 2003) ,
we calculated the diameter and concentration of QDs from the UV-visible absorption spectra. For the as-prepared CdTe QDs, the diameter of QDs was about 3.36 nm and the molarity of 10 μg/mL stock solution was about 22.7 nM.
In this study, we used MSA as the surface coating to protect the QDs core. The concentration of mercaptosuccinate capping ligands was assessed by measuring the TOC. The TOC content in 10 μg/mL QDs stock solution was about 0.686 ± 0.03 μg/mL. Because the TOC in mercaptosuccinate (C 4 H 5 O 4 S -) was about 32% of the total mass, the content of MSA can be calculated as 2.14 ± 0.03 μg/mL. On the other hand, the concentration of Cd from the 10 μg/mL QDs stock solution was determined as 5.77 ± 0.16 μg/mL by AAS. Based on these above results, the formula Fig.2B showed that the MFI at peak emission of MSA-capped CdTe QDs under a weak acidic condition (pH = 5) was slightly lower than that under a physiological condition (pH = 7.4) through the tested period. But the commercial CdTe QDs, which was capped with unknown micromolecule organic acid, appears to completely lose its fluorescence when the pH value was adjusted to 5.
Hence, our MSA-capped CdTe QDs have favorable properties of being water-soluble and highly pH stable, and present promising prospects in the biomedical applications.
CdTe QDs decreases cell viability of HUVECs in a dose-dependent manner
To examine the direct toxic effects on vascular ECs, cultured HUVECs were treated with CdTe QDs for 24 h. As shown in Fig.3A , CdTe QDs dose-dependently decreased the cell viability of HUVECs, as a gradual decline in cellular calcein fluorescence was observed in the presence of 0.1~10 μg/mL CdTe QDs. MTT assay showed that significant cell death was observed with CdTe QDs at a concentration of 1 μg/mL and above (Fig.3B, p<0 .01, one-way ANOVA). The TC 50 value (concentration of CdTe QDs causes 50% cell death) was found at 10.60 μg/mL (about 24.06 nM) determined by log-logit transformation, indicating the remarkable endothelial toxicity of CdTe QDs.
CdTe QDs lead to apoptotic cell death of HUVECs
To further assess the extent of QDs-induced injuries, we detected the apoptosis in 15 QDs-treated HUVECs by flow cytometry, using an Annexin-V apoptosis detection kit.
The translocation of PS from the inter leaflet of the plasma membrane to outer leaflet, and then can be labeled by Annexin-V, is one of the typical features of cells undergoing apoptosis process. After 24 h incubation with QDs , the percentages of Annexin-V-positive HUVECs (Fig.4) increased gradually depending on CdTe QDs concentration (4.48 ± 1.17% at control, 4.73 ± 0.81% at 0.1 μg/mL, 6.37 ± 0.35% at 1 μg/mL and 22.49 ± 1.34% at 10 μg/mL, p<0.01, one-way ANOVA). These results suggested that CdTe QDs could induce rapid apoptosis of HUVECs, and exerted direct pro-apoptotic effects in a dose-dependent manner.
CdTe QDs elevate intracellular ROS levels and subsequent mitochondrial dysfunction in HUVECs
The effect of QDs on ROS generation in HUVECs was assessed by measuring the oxidation of DCFH-DA to DCF using flow cytometer. The exposure of HUVECs to CdTe QDs for 12 h resulted in a dose-dependent increase of intracellular ROS (Fig.5B) . Compared with control, 0.1, 1 and 10 μg/mL CdTe QDs significantly promoted ROS generation by 77.76%, 100.97% and 119.35% in HUVECs, respectively (p<0.05, one-way ANOVA). However, the intracellular ROS content was gradually increased to 138.10% of control at 0.1 μg/mL and 135.63% of control at 1 μg/mL after 24 h incubation, and it even restored to 2.63% lower than the control value at 10 μg/mL group (Fig.5B) . These results revealed that CdTe QDs-induced elevation of intracellular ROS production may be earlier than the apoptosis, suggesting ROS might play a role in CdTe QDs-induced apoptosis of HUVECs.
Since oxidative stress is known to impair mitochondria, whose functions are essential for maintaining cellular homeostasis, we studied the effect of CdTe QDs on Altogether, these data indicated that QDs-caused intracellular ROS elevation was directly involved not only in the QDs-induced mitochondrial injury but also in 17 QDs-induced apoptosis.
CdTe QDs activated the mitochondrial apoptosis pathways in HUVECs
Besides maintaining cellular metabolism, mitochondria have also been shown to fulfill very important functions in the signal transduction for apoptosis. Therefore, to further investigate the molecular mechanism of CdTe QDs-induced HUVECs apoptosis, we detected the expression of mitochondrial apoptosis regulatory proteins by immunoblotting analysis. The expression level of the pro-survival Bcl-2 in HUVECs dramatically decreased, whereas the level of the pro-apoptotic Bax significantly increased after 24 h of treatment (Fig. 9A ). Because Bax is involved in release of cytochrome c, which subsequently triggers activation of caspase proteases and death of a cell by apoptosis, we then examined the subcellular distribution of cytochrome c by immunofluorescence. Cytochrome c, as a component of the electron transport chain, is found loosely associated with the inner membrane of the mitochondrion. Indeed, in control cells, the cytochrome c (green, Fig.8A ) showed punctuate staining in the cytoplasm/perinuclear region, and it was well co-localized with the mitochondria (red, Fig.8B and C) . In contrast, when the HUVECs treated with 10 μg/mL CdTe QDs for 24 h, the staining for cytochrome c in those cells was not punctate and perinuclear but, rather, diffuse (Fig.7E ). There was scarce overlay with mitochondria can be observed in QDs-treated HUVECs ( Fig.8D and F) ,
suggesting that the bulk of cytochrome c leaked from endothelial mitochondria after QDs treatment. Collectively, these results indicated that the protein expression of pro-apoptotic molecules increased in CdTe QDs-treated HUVECs.
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The initiator caspase-9 and effector caspase-3, which play vital roles in the mitochondrial-dependent apoptotic pathway of cells, were both activated in HUVECs following treatment with CdTe QDs, because the immumoblotting analysis showed that the cleavage of both caspase-9 and caspase-3 could be detected after 24 h CdTe QDs treatment (Fig.9B) . The pan-caspase inhibitor Z-VAD-FMK and specific caspase-3 inhibitors Ac-DEVD-CHO were used to analyze the involvement of caspases in CdTe QDs-induced apoptosis in HUVECs. As shown in Fig. 8B , the pre-treatment of HUVECs with either Z-VAD-FMK or Ac-DEVD-CHO significantly decreased CdTe QDs-induced apoptosis to 7.48 ± 1.03% and 13.07 ± 0.98%. Taken together, our results showed that CdTe QDs directly activated the intrinsic mitochondrial apoptosis pathway in HUVECs, and this apoptotic process was clearly caspase-dependent.
Discussion
The present study demonstrated that MSA-capped CdTe QDs directly caused Besides that, our data of element composition determination and Cd 2+ leakage assay confirmed that our CdTe core QDs was well capped with MSA, that was reported to provide more excellent stabilities of QDs against aggregation at low pH than mostly employed mercaptoacetic acid (MPA) or dihydrolipoic acid (DHLA) (Algar and Krull 2007). In fact, our as-prepared QDs have efficient luminescence, and they do have higher pH stability (Fig.2B) than that of a similar commercial QDs. Hence, our QDs with excellent optical properties are suitable for biomedical applications such as bioimaging, composite drug delivery or disease diagnosis agents. However, little is known whether QDs affect endothelial function when they enter vasculature through injection as the imaging agents. Therefore, employing HUVECs as an in vitro model, we explored the potential endothelial toxicity of these MSA-capped CdTe QDs.
In this study, we tested the endothelial toxicity of MSA-capped CdTe QDs in the concentration range from 0.1 to 100 μg/mL (coresp. molarity was about 0.227 nM to 227 nM). According to previous reports, the concentration which we tested in our following experiments is similar to the doses that have actually used in in vivo bioimaging (up to hundreds of nanomole) (Ballou et al. 2007; Ballou et al. 2004; Cai et al. 2006; Gao et al. 2004; Jayagopal et al. 2007; Larson et al. 2003; Tada et al. 2007) or tested in other in vitro toxicological studies (up to hundreds of nanomole or μg/mL) 20 (Chang et al. 2009; Chen et al. 2010; Choi et al. 2007; Lovric et al. 2005; Su et al. 2009; Su et al. 2010; Tang et al. 2008; Wu et al. 2010) . Then, our cell viability assays (Fig. 3) revealed that CdTe QDs caused significant cell loss in a dose-dependent manner (at or above 0.1 μg/mL), demonstrating CdTe QDs manifested cytotoxic effect against HUVECs. Quantitive cytometric analysis disclosed that, in HUVECs, exposure to CdTe QDs induced dose-dependent apoptotic cell death (Fig.4) , which might compromise vasoregulation, increase smooth muscle cells (SMCs) proliferation and/or migration and facilitate blood clotting (Bombeli et al. 1997; Busse et al. 1985; Raymond et al. 2004) , leading to CVDs such as atherosclerosis and thrombus.
Notably, the concentration of CdTe QDs required to promote endothelial toxicity (TC 50 ) in our study was much lower than most of that in other cell types (Chen et al. 2010; Choi et al. 2007 ,(Su et al. 2010 , (Su et al. 2009; Wu et al. 2010) , (Chang et al. 2009; Chen et al. 2010; Choi et al. 2007; Lovric et al. 2005; Shiohara et al. 2004; Tang et al. 2008) . A possible explanation for this difference is that the tested cell types have different cellular sensitivity to QDs. In other words, vascular ECs are more susceptible to damage by QDs.
QDs were reported to generate reactive singlet oxygen species (Samia et al. 2003) .
To explore if QD could induced overabundant intracellular ROS and if that was tightly associated with their endothelial toxicity (Cho et al. 2007 ), we measured the ROS intensity and potential injuries of mitochondrial functions in QDs-treated
HUVECs. Here we observed that QDs treatment could trigger a twofold elevation of intracellular ROS (Fig. 5) , followed by obvious disruption of Δψ m (Fig.6B) , which 21 could be inhibited by ROS scanvenager NAC (Fig.7) , as well as mitochondrial fragmentation (Fig.6C) . Hence, considering the free Cd 2+ released from MSA-capped CdTe QDs is little ( Fig.2A) , we suppose that QDs-induced endothelial toxicity was mostly mediated by elevated intracellular ROS; and mitochondria may be a major target organelle. This undesirable oxidative damage caused by QDs also reminder that the surface modification of QDs, which may reduce the production of ROS, is of Furthermore, the present study found that QDs directly activated the intrinsic mitochondrial apoptosis pathway, which is widely involved in vascular diseases (Davidson and Duchen 2007; Tanaka et al. 2003; Vindis et al. 2005) . After 24 h incubation, CdTe QDs caused an increase of pro-apoptotic Bax but a decrease of pro-survival Bcl-2 (Fig.9A) ; and they also caused the release of cytochrome c (Fig.8)， accompanied by the cleavage of caspase-9 and caspase-3 (Fig.9A) . Moreover, the apoptosis caused by CdTe QDs was significantly reduced by caspase inhibitors (Fig.9B) , indicating caspases are essential for CdTe QDs-induced apoptosis in ECs. It is noteworthy that our result is different from the previous study by Lovrić et al., in which they observed that QDs-induced cell death was caspase-independent in cells with caspase-3 expression (PC12 cells) or without (MCF-7 cell line) (Lovric et al. 2005b) . As the QDs used in two studies were of similar composition, the same dose (10 μg/mL) and induced similar impairments of mitochondria in all three cell types, the discrepancy of downstream apoptosis signal components of mitochondria seemed to arise from different cell types. Collectively, the understanding of the mechanism underlying QDs-induced cell death is still far from complete, and may be complicated by cell types and signaling context differences.
In conclusion, we have demonstrated for the first time that QDs increased the 23 generation of intracellular ROS, impaired mitochondrial functions, activated the mitochondrial apoptosis pathway and finally promoted apoptotic cell death in HUVECs. Our overall findings provided strong evidence that the QDs circulating in blood was a potential significant risk factor for CVDs. With increased utilization of QDs in biomedical research as well as the potential clinical usage, these data also offer helpful guidance on future safe use of QDs and help researchers improve the manipulation of QDs to make them more suitable tools in life science.
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